Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,410.27
2,812.66
4,093.05
5,069.48
3,443.01
2,921.65
1,112.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,410.27
2,812.66
4,093.05
5,069.48
3,443.01
2,921.65
1,112.25
Raw Material Cost
750.78
756.59
683.77
668.34
438.81
426.96
271.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
341.64
243.85
170.83
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
8.75
6.30
7.86
6.47
2.08
32.67
Selling and Distribution Expenses
1,327.32
1,145.01
1,830.79
2,264.49
1,570.64
1,287.90
602.84
Other Expenses
22.42
49.71
73.17
89.90
24.94
-7.97
-16.85
Total Expenditure (Excl Depreciation)
2,302.30
2,407.42
3,252.60
3,839.68
2,606.99
1,881.07
909.57
Operating Profit (PBDIT) excl Other Income
108
405.20000000000005
840.5
1229.8
836
1040.6
202.7
Other Income
145.02
214.67
186.38
165.44
174.95
65.90
55.34
Operating Profit (PBDIT)
626.73
703.03
1,173.58
1,554.32
1,151.74
1,230.31
332.14
Interest
0.00
8.75
6.30
7.86
6.47
2.08
32.67
Exceptional Items
-47.98
-98.34
-235.35
-199.42
-285.84
273.29
9.74
Gross Profit (PBDT)
1,659.48
2,056.07
3,409.28
4,401.14
3,004.19
2,494.69
840.49
Depreciation
411.75
411.57
333.34
275.50
149.55
128.40
82.22
Profit Before Tax
167.00
184.37
598.59
1,071.54
709.88
1,373.12
226.99
Tax
40.96
10.10
87.65
132.24
107.59
162.12
35.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
177.74
142.16
419.39
728.65
427.75
1,003.19
141.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
177.74
142.16
419.39
728.65
427.75
1,003.19
141.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-52.58
32.24
91.93
209.57
173.60
208.00
52.16
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
125.16
174.40
511.33
938.23
601.35
1,211.19
194.14
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,620.99
9,429.54
9,349.28
9,083.97
8,484.23
6,544.76
4,865.16
Earnings per share (EPS)
0.11
0.09
0.26
0.45
0.27
0.65
0.09
Diluted Earnings per share
0.11
0.09
0.26
0.45
0.27
0.65
0.09
Operating Profit Margin (Excl OI)
2.9%
2.73%
15.97%
21.96%
24.03%
35.46%
17.49%
Gross Profit Margin
24.01%
21.19%
22.77%
26.57%
24.96%
51.39%
27.8%
PAT Margin
7.37%
5.05%
10.25%
14.37%
12.42%
34.34%
12.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -14.31% vs -31.28% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -28.21% vs -65.89% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -1.37% vs -50.53% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -100.00% vs 38.10% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Walvax Biotechnology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,410.27
0
2,410.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,410.27
0
2,410.27
Raw Material Cost
750.78
0
750.78
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
1,327.32
0
1,327.32
Other Expenses
22.42
0.00
22.42
Total Expenditure (Excl Depreciation)
2,302.30
0
2,302.30
Operating Profit (PBDIT) excl Other Income
107.97
0.00
107.97
Other Income
145.02
0
145.02
Operating Profit (PBDIT)
626.73
0
626.73
Interest
0.00
0
0.00
Exceptional Items
-47.98
0
-47.98
Gross Profit (PBDT)
1,659.48
0
1,659.48
Depreciation
411.75
0
411.75
Profit Before Tax
167.00
0
167.00
Tax
40.96
0
40.96
Provisions and contingencies
0
0
0.00
Profit After Tax
177.74
0
177.74
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
177.74
0
177.74
Share in Profit of Associates
0
0
0.00
Minority Interest
-52.58
0
-52.58
Other related items
0.00
0.00
0.00
Consolidated Net Profit
125.16
0
125.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,620.99
0
8,620.99
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
2.90%
0%
0.00
2.90%
Gross Profit Margin
24.01%
0%
0.00
24.01%
PAT Margin
7.37%
0%
0.00
7.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 241.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -14.31% vs -31.28% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 12.52 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -28.21% vs -65.89% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 48.17 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.37% vs -50.53% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.90%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






